event
Global Health Centre
Thursday
25
May
global health r&d stage

Global Health R&D: How can we best set priorities based on evidence?

, -

Auditorium A1 | Maison de le Paix

This event will discuss different endeavours to monitor and analyse R&D activities, to inform global priority setting and to promote coordination of investments in product-related health R&D

Add to Calendar

Progress towards achieving universal health coverage and health for all by 2030 requires establishing and sustaining health information systems that continuously provide evidence to facilitate and guide target-oriented investments in R&D for diseases, including for products marked by different types of market failure. Despite an increase in R&D activities for a range of poverty-related diseases primarily affecting low and middle-income countries, significant R&D gaps remain. A major challenge is the fragmented R&D landscape which leads to inefficient resource allocation. Evidence-based global priority setting and facilitating the coordination between major R&D organisations are crucial in view of the limited resources available for product-related health R&D benefitting poverty-related diseases.
   

This side event will discuss different endeavours to monitor and analyse R&D activities, to inform global priority setting and to promote coordination of investments in product-related health R&D. Among others, the event will introduce: the newly established Global Observatory for Health R&D and its systematic mapping of health R&D activities; the current work on an open-access online resource that includes the WHO validated goals for health products and their targeted diseases; as well as a directory containing a wide array of product profile characteristics developed by WHO and other entities. All these initiatives ultimately aim to inform and facilitate the priority setting for new R&D investments.  

Furthermore, the event will present other data collection mechanisms to track R&D activities and efforts to develop standards for R&D data classification, including common reporting formats, such as the G7 technical working group.
    
All these initiatives will set the agenda for the new Expert Committee on Health R&D to provide advice on Global R&D priorities that would be supported by a potential health product R&D fund and other existing R&D financing mechanisms.
     
Join us for this panel discussion. You are required to register online your attendance, free of charge.

This event is co-organised by Switzerland, South Africa, and the European Commission.

Event materials

Programme

List of participants

Photo gallery

Presentation: Dr Vasee Moorthy

Presentation: Robert Terry

Presentation: Kevin McCarthy

 

Event recording